If you've been reading about longevity peptides, these two names show up close together, and it's easy to assume they're interchangeable. They aren't, quite. Pinealon and Epithalon come from the same research lineage and share a similar theory of how they work, but researchers point them at different problems. If you're trying to decide which one you're actually curious about, the difference comes down to a simple question. Are you thinking about your brain, or about aging more broadly? (One quick note on spelling. You'll see Epithalon written as Epitalon too, and both refer to the same peptide.)
What Pinealon and Epithalon have in common
Both are very short synthetic peptides, chains of just a few amino acids, developed by the Russian gerontologist Vladimir Khavinson and colleagues as part of a family they call "short peptide bioregulators." The shared idea is that a tiny peptide can act like a signal that reaches inside the cell and influences which genes are switched on. Both are sold for research as freeze-dried powder, and, importantly, both rest on an evidence base that is early, narrow, and mostly produced by the same circle of laboratories.
How Pinealon works
Pinealon is a tripeptide, three amino acids, written Glu-Asp-Arg. The research on it centers on the brain. In cell and animal studies, it reduced levels of free radicals, the unstable molecules that damage cells, and it was studied for protecting neurons under stress and supporting memory and learning. The proposed mechanism is that the peptide enters the cell nucleus and binds to specific stretches of DNA, which is how its developers think it nudges gene activity in brain cells. Think of Pinealon's research story as a neuroprotection story.
How Epithalon works
Epithalon is a tetrapeptide, four amino acids, written Ala-Glu-Asp-Gly. Its research story is about cellular aging rather than the brain specifically. The headline interest is telomeres, the protective caps on the ends of your chromosomes that shorten as cells divide over a lifetime. Lab studies have looked at whether Epithalon can influence telomerase, the enzyme that maintains those caps. It's also tied to the pineal gland and melatonin, the hormone that governs the sleep and wake cycle, which is where the longevity-and-body-clock framing comes from. So Epithalon's research story is a cellular-longevity story.
Key differences
The clearest difference is the target of the research. Pinealon work is about the aging brain, neurons, oxidative stress, memory. Epithalon work is about aging at the cellular level, telomeres, and the body clock. Someone drawn to Pinealon is usually thinking about cognition and mental sharpness. Someone drawn to Epithalon is usually thinking about longevity and cellular aging in a broader sense.
The second difference is how much attention each has gathered. Epithalon is the far more famous of the two, largely because the telomere angle taps into one of the most talked-about ideas in the longevity world. Pinealon is comparatively obscure, studied by a smaller set of researchers and discussed far less. More fame doesn't mean more proof, though, and that's the trap to avoid here.
Which brings us to the most important similarity, dressed up as a difference. On paper you could tell these two apart by their evidence. In practice, both share the same core limitation. The published research for each is dominated by cell studies and animal models, much of it from the same original labs, with little independent replication and no large, well-controlled human trials establishing what either does in people, at what amount, or how safe it is over time. If you were hoping one of these had a meaningfully stronger human track record than the other, the honest answer is that neither does yet.
Cost tends to be similar as well, since both are short synthetic peptides sold in the same corner of the research market. Price usually turns on vial size, vendor, and purity rather than on which peptide it is, so the per-mg math is the thing to compare, not the name on the vial.
| Pinealon | Epithalon | |
|---|---|---|
| Structure | Tripeptide (Glu-Asp-Arg) | Tetrapeptide (Ala-Glu-Asp-Gly) |
| Research focus | Aging brain, neuroprotection | Telomeres, cellular longevity |
| Also linked to | Memory, oxidative stress | Pineal gland, melatonin |
| Evidence base | Cell and animal studies | Cell and animal studies |
| Human trials | None large-scale | None large-scale |
| Best for the curious about | Cognition and brain aging | Longevity and cellular aging |
Bottom line
If the thing pulling you in is your brain, the fuzzy memory, the midlife mental fog, the wish to protect cognition as you age, then Pinealon is the one whose research actually speaks to that. It's the more targeted choice for someone whose question is specifically about the mind.
If you're thinking about aging in the bigger picture, cellular longevity, telomeres, the body clock, then Epithalon is the one that matches. It's the better fit for the broad longevity researcher rather than the person focused on cognition. Just carry the same caveat into either choice. Both are early-stage compounds with promising laboratory signals and no confirmed human benefit yet, so hold the excitement and the uncertainty together, and talk to a qualified healthcare provider if you're considering either one.
Where to go from here
For the full citation list and study-by-study breakdown, read the Pinealon research notes and the Epithalon research notes. If you want to see how the per-mg pricing actually shakes out between them, you can compare current prices in the tool.